Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

ÖZGÜR ÖZYILKAN

Profesör

Başkent Üniversitesi

Research topics OpenAlex
Articles 155 YÖKSİS 155 · OpenAlex 0 Total citations 8,566 h-index 20 · OpenAlex OpenAlex coverage %46 matched 71 / 154 Q1 articles 29 Scopus · WoS Q1 17 Co-authors 83 20 Turkish institutions

Citation impact

Citation counts of the articles matched in OpenAlex, citing publications from Crossref and the Stanford/Elsevier list. Sources are shown separately and never added up.

OpenAlex YÖKSİS articles matched in OpenAlex: 71 + YÖKSİS · co-author record: 18
h-index 20 Percentile in Türkiye: 96 #21 of 1,091 at their university by h-index
i10-index
36
Total citations
8,566
Top 0.2% in Türkiye
Per article
96.2
FWCI
5.72
1.00 = world average
World top 1%
3
World top 10%
8

Most cited articles

  1. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial 2019 world top 1% 3,390 citations
  2. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study 2019 world top 1% 3,349 citations
  3. Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial 2019 world top 1% 619 citations
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 18 articles (264 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.

Citing publications Crossref 2,322 publications citing 73 DOI-bearing articles · 45 Türkiye-affiliated
  • 2012 1
  • 2019 121
  • 2020 717
  • 2021 1,048
  • 2022 307
  • 2023 1
  • 2025 108
  • 2026 19
  1. DOI 10.1016/j.canlet.2025.218203 2026
  2. DOI 10.1001/jamaoncol.2025.5241 2026
  3. DOI 10.1016/j.oraloncology.2025.107814 2026
  4. DOI 10.26599/nr.2025.94908300 2026
  5. DOI 10.1016/j.oraloncology.2025.107809 2026
  6. DOI 10.1016/j.intimp.2025.115988 2026
  7. DOI 10.1016/j.canlet.2025.218135 2026 · cites 2 articles of this academic
  8. DOI 10.1016/j.isci.2025.114429 2026
  9. DOI 10.1001/jamaoto.2025.4573 2026
  10. DOI 10.1016/j.anl.2025.11.006 2026
  11. DOI 10.1016/j.tranon.2025.102579 2026
  12. DOI 10.1016/j.otc.2025.09.004 2026
  13. DOI 10.1001/jama.2025.21733 2026
  14. DOI 10.1016/j.thorsurg.2025.09.008 2026
  15. DOI 10.1016/j.suronc.2025.102340 2026
  16. DOI 10.1016/j.joim.2025.10.007 2026
  17. DOI 10.1016/j.annonc.2025.10.1239 2026
  18. DOI 10.1080/19466315.2025.2587046 2026
  19. DOI 10.1016/j.ando.2025.102470 2026
  20. Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor TR Yeong Hak Bang et al. · Journal for ImmunoTherapy of Cancer · 2025
  21. DOI 10.1038/s41467-025-66801-w 2025
  22. DOI 10.1158/1078-0432.ccr-25-1603 2025
  23. DOI 10.1007/s44217-025-00950-4 2025
  24. DOI 10.1016/j.clnesp.2025.10.031 2025
  25. DOI 10.1038/s41598-025-29173-1 2025
  26. DOI 10.1007/s00428-025-04354-5 2025 · cites 2 articles of this academic
  27. DOI 10.1002/cnr2.70369 2025
  28. DOI 10.1186/s12931-025-03429-w 2025
  29. DOI 10.1097/scs.0000000000012267 2025
  30. DOI 10.1097/rlu.0000000000006151 2025

Showing the 30 most recent.

Where does this list come from?

Extracted from the reference lists in Crossref’s public March 2026 data file; 18.4% of the file has been processed, so the list may be incomplete. Crossref citations are never added to or compared with the OpenAlex citation counts; the two sources have different coverage.

Works 155

YÖKSİS and OpenAlex records: index distribution, journals published in, a filterable article list and the other output types.

Indexes and citation percentiles

?
TR Index 8 articles
OpenAlex citation percentile
Top 1%3
Top 10%6
Avg · n 73 %59.9
Other counts

Scopus (SJR)

  • YÖKSİS rows 89

WoS (JCR)

  • YÖKSİS rows 97

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

155articles

Journals with publications

60 journals

Narrow down

Scopus (SJR)
Q129 Q231 Q326 Q43
WoS (JCR)
Q117 Q29 Q327 Q443
TR Index
8articles

Article list

  1. 2025 Evaluation of implementation of evolving practice patterns in the first-line treatment of patients with metastatic non-small cell lung cancer in Turkiye (ESTIMATE): a national, multicenter, retrospective, real-world evidence study FUTURE ONCOLOGY DOI 10.1080/14796694.2025.2527477 YÖKSİS SJR Q1 JCR Q2 OpenAlex 22.0%
  2. 2023 Pertuzumab Aracılı Kardiyotoksisite: Tek Merkezli Bir Çalışma Sakarya Medical Journal DOI 10.31832/smj.1163527 YÖKSİS OpenAlex 42.8%
  3. 2023 Pertuzumab-mediated Cardiotoxicity: A Single Center Study. Sakarya Tıp Dergisi DOI 10.31832/smj.1163527 YÖKSİS TR Index OpenAlex 43.0%
  4. 2021 nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer CLINICAL BREAST CANCER DOI 10.1016/j.clbc.2020.09.011 YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 92.9%
  5. 2021 Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study JOURNAL OF ONCOLOGY PHARMACY PRACTICE DOI 10.1177/1078155220963535 YÖKSİS SJR Q3 JCR Q4 OpenAlex 16.5%
  6. 2020 Palyatif Bakımda Kanser Hastaları İçin Nütrisyonel Destek Turkiye Klinikleri Medical Oncology - Special Topics YÖKSİS
  7. 2020 Kanser Hastalarında Kemik ve Kas Sağlığı Turkiye Klinikleri Medical Oncology - Special Topics YÖKSİS
  8. 2020 GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients LUNG CANCER DOI 10.1016/j.lungcan.2020.07.022 YÖKSİS SJR Q1 JCR Q1 OpenAlex 88.6%
  9. 2020 Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG) JOURNAL OF CANCER EDUCATION DOI 10.1007/s13187-018-1441-6 YÖKSİS SJR Q2 JCR Q3 OpenAlex 54.7%
  10. 2019 Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy CANCER MANAGEMENT AND RESEARCH DOI 10.2147/CMAR.S222297 YÖKSİS SJR Q3 JCR Q3 OpenAlex 81.8%
  11. 2019 Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study LANCET DOI 10.1016/S0140-6736(19)32591-7 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%
  12. 2019 Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial LANCET ONCOLOGY DOI 10.1016/S1470-2045(19)30634-5 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.9%
  13. 2019 Addition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of Turkish Oncology Group JOURNAL OF BUON YÖKSİS SJR Q3 JCR Q4
  14. 2019 Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) ANNALS OF ONCOLOGY DOI 10.1093/annonc/mdz061 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 97.0%
  15. 2019 Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial LANCET DOI 10.1016/S0140-6736(18)32409-7 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%
  16. 2018 Clinicohistopathological features and treatment outcomes of neuroendocrine tumors: a single center experience CUKUROVA MEDICAL JOURNAL DOI 10.17826/cumj.335741 YÖKSİS TR Index JCR Q3 OpenAlex 5.4%
  17. 2018 Risk Factors for Fatal Pulmonary Hemorrhage following Concurrent Chemoradiotherapy in Stage 3B/C Squamous-Cell Lung Carcinoma Patients JOURNAL OF ONCOLOGY DOI 10.1155/2018/4518935 YÖKSİS SJR Q2 JCR Q3 OpenAlex 62.7%
  18. 2018 Incidence and Impact of Pretreatment Tumor Cavitation on Survival Outcomes of Stage III Squamous Cell Lung Cancer Patients Treated With Radical Concurrent Chemoradiation Therapy INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS DOI 10.1016/j.ijrobp.2018.04.053 YÖKSİS SJR Q1 JCR Q1 OpenAlex 65.3%
  19. 2018 A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey - NOTES study ONCOTARGETS AND THERAPY DOI 10.2147/OTT.S148917 YÖKSİS SJR Q2 JCR Q2 OpenAlex 64.8%
  20. 2017 Flare Phenomenon in Advanced Colorectal Cancer: Cessation of evacizumab after Predefined Cycles of Therapy may not Affect Outcome UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI DOI 10.4999/uhod.171617 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 55.0%

Projects 16 See all (16) →

  1. — KA09 237 Türkiye deki kolorektal kanser vakalarının profili ile ilgili kesitsel bir kayıt çalışması OXALI L 00657 KOLON TÜRK ARAŞTIRMA PROJESİ · Tamamlandı
  2. — KA09 127 Klinikte ölen terminal dönem kanserli hastalarda son iki hafta içinde yapılan tetkik ve tedavilerin retrospektif analizi 31 03 2009 ARAŞTIRMA PROJESİ · Tamamlandı
  3. — KA12 266 Küçük hücre dışı akciğer karsinomu tanısı alan hastalarda patolojik altgrup analizi ve sağkalım üzerine olan etkilerine bakmak Cemile Karadeniz 13 12 2012 ARAŞTIRMA PROJESİ · Tamamlandı
  4. — KA12 186 2006 2011 tarihleri arasında Başkent Üniversitesi Adana Uygulama ve Araştırma Merkezine başvuran küçük hücre dışı akciğer karsinomu tanısı almış olan hastalarda alt sub grup analizi ve hastaların demografik özellikleri evresi ve aldığı tedavileri gözden geçirerek sağkalım sürelerini değerlendirmek patolojik tanılarında TTF 1 ve CK 20 sonuçlarını değerlendirmek Cemile Karadeniz 27 07 2012 ARAŞTIRMA PROJESİ · Tamamlandı
  5. — KA11 260 Onkoloji hastalarında gelişen böbrek sorunları Ayşegül Zümrütdal 30 12 2011 ARAŞTIRMA PROJESİ · Tamamlandı

Proceedings 3

  1. — EVALUATION OF CERULOPLASMIN LEVEL IN WOMEN WITH BREAST DISEASE - PRELIMINARY-RESULTS ESMO
  2. — EVALUATION OF CERULOPLASMIN LEVEL IN WOMEN WITH BREAST DISEASE - PRELIMINARY-RESULTS Chemotherapy
  3. — EVALUATION OF CERULOPLASMIN LEVEL IN WOMEN WITH BREAST DISEASE - PRELIMINARY-RESULTS Chemotherapy congress

← Back to academicians

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
83
With an akaturk profile
44
Turkish institutions
20
Co-authored works
%56

Academic co-authors 44

  1. ALİ AYBERK BEŞEN Profesör · İstanbul Aydın Üniversitesi 23
  2. FATİH KÖSE Profesör · Başkent Üniversitesi same university 22
  3. ZAFER AKÇALI Profesör · Başkent Üniversitesi same university 15
  4. OZAN CEM GÜLER Profesör · Başkent Üniversitesi same university 5
  5. ÖZGÜR TANRIVERDİ Profesör · Muğla Sıtkı Koçman Üniversitesi 4
  6. FAZİLET KAYASELÇUK Profesör · Başkent Üniversitesi same university 3
  7. HÜSEYİN CEM ÖNAL Profesör · Başkent Üniversitesi same university 3
  8. SERCAN AKSOY Profesör · Hacettepe Üniversitesi 3
  9. TUĞBA YAVUZŞEN Profesör · Dokuz Eylül Üniversitesi 3
  10. YURDAY ÖZDEMİR Doçent · Başkent Üniversitesi same university 3
Show all (44)
  1. ÖZDEN ALTUNDAĞ Profesör · Başkent Üniversitesi same university 3
  2. AYNUR DOĞRUSÖZ Doçent · Başkent Üniversitesi same university 2
  3. EMİN TAMER ELKIRAN Profesör · İnönü Üniversitesi 2
  4. FEYYAZ ÖZDEMİR Profesör · Karadeniz Teknik Üniversitesi 2
  5. MEHMET ARTAÇ Profesör · Necmettin Erbakan Üniversitesi 2
  6. MÜŞERREF ŞULE AKÇAY Profesör · Başkent Üniversitesi same university 2
  7. RÜKSAN ÇEHRELİ Doktor Öğretim Üyesi · İzmir Ekonomi Üniversitesi 2
  8. SAADETTİN KILIÇKAP Profesör · İstinye Üniversitesi 2
  9. YASEMİN AKÇAY Profesör · Ege Üniversitesi 2
  10. ZEYNEP HANDE TURNA Profesör · İstanbul Üniversitesi-Cerrahpaşa 2
  11. İBRAHİM HALDUN MÜDERRİSOĞLU Profesör · Başkent Üniversitesi same university 2
  12. İRFAN ÇİÇİN Profesör · İstinye Üniversitesi 2
  13. İSMAİL ÇELİK Profesör · Hacettepe Üniversitesi 2
  14. ABDULLAH TEKİN Profesör · Başkent Üniversitesi same university 1
  15. ALİ ALKAN Doçent · Muğla Sıtkı Koçman Üniversitesi 1
  16. BİNNAZ HANDAN ÖZDEMİR Profesör · Başkent Üniversitesi same university 1
  17. FİLİZ ÇAY ŞENLER Profesör · Ankara Üniversitesi 1
  18. HAKAN AKBULUT Profesör · Ankara Üniversitesi 1
  19. HALUK ERDOĞAN Profesör · Alanya Alaaddin Keykubat Üniversitesi 1
  20. HÜSEYİN LAKADAMYALI Profesör · Alanya Alaaddin Keykubat Üniversitesi 1
  21. MEHMET AKİF ÖZTÜRK Profesör · Üsküdar Üniversitesi 1
  22. MELEK EDA ERTÖRER Profesör · Başkent Üniversitesi same university 1
  23. MUHAMMET BEKİR HACIOĞLU Profesör · Trakya Üniversitesi 1
  24. NADİRE KÜÇÜKÖZTAŞ Profesör · Bolu Abant İzzet Baysal Üniversitesi 1
  25. NESLİHAN BAŞÇIL TÜTÜNCÜ Profesör · Başkent Üniversitesi same university 1
  26. NURİ FARUK AYKAN Profesör · İstinye Üniversitesi 1
  27. RİAN DİŞÇİ Profesör · İstanbul Beykent Üniversitesi 1
  28. SIDDİKA SONGÜL YALÇIN Profesör · Hacettepe Üniversitesi 1
  29. TAHA YUSUF KUZAN Doçent · Sağlık Bilimleri Üniversitesi 1
  30. ÖMER TOPRAK Doçent · Balıkesir Üniversitesi 1
  31. İBRAHİM HAKAN GÜLLÜ Profesör · Sağlık Bilimleri Üniversitesi 1
  32. İLKER ÜNAL Profesör · Çukurova Üniversitesi 1
  33. İSMAİL BEYPINAR Doçent · Alanya Alaaddin Keykubat Üniversitesi 1
  34. ŞAHİKA ZEYNEP AKI Profesör · Sağlık Bilimleri Üniversitesi 1

National collaboration 20 institutions

Within own university55 joint works · Başkent Üniversitesi

  1. İstanbul Aydın Üniversitesi 23 works · 1 academics
  2. Hacettepe Üniversitesi 5 works · 3 academics
  3. Muğla Sıtkı Koçman Üniversitesi 4 works · 2 academics
  4. İstinye Üniversitesi 4 works · 3 academics
  5. Dokuz Eylül Üniversitesi 3 works · 1 academics
  6. Sağlık Bilimleri Üniversitesi 3 works · 3 academics
  7. Alanya Alaaddin Keykubat Üniversitesi 2 works · 3 academics
  8. Ankara Üniversitesi 2 works · 2 academics
  9. Ege Üniversitesi 2 works · 1 academics
  10. Karadeniz Teknik Üniversitesi 2 works · 1 academics
Show all (20)
  1. Necmettin Erbakan Üniversitesi 2 works · 1 academics
  2. İnönü Üniversitesi 2 works · 1 academics
  3. İstanbul Üniversitesi-Cerrahpaşa 2 works · 1 academics
  4. İzmir Ekonomi Üniversitesi 2 works · 1 academics
  5. Balıkesir Üniversitesi 1 works · 1 academics
  6. Bolu Abant İzzet Baysal Üniversitesi 1 works · 1 academics
  7. Trakya Üniversitesi 1 works · 1 academics
  8. Çukurova Üniversitesi 1 works · 1 academics
  9. Üsküdar Üniversitesi 1 works · 1 academics
  10. İstanbul Beykent Üniversitesi 1 works · 1 academics

Other co-authors (incl. international) 39

AHMET TANER SÜMBÜL 25AHMET SEZER 23HÜSEYİN MERTSOYLU 7Parlak C. 6Topkan E. 5PERRAN FULDEN YUMUK 3Topuk S. 3Yildirim Yesim 3AYŞENUR UÇAR 2Demirhan Beyhan 2Emiroglu Remzi 2Haberal Mehmet 2Karakayali Hamdi 2NİYAZİ GÜLER 2AKPEK GAkcali WBALTALLI EBARISTA IBilezikci BCEYDA KARADENİZCanbolat T.Disel U.EVRİM METCALFEFATMA IŞIL BULUTFIRAT DFilik L.GULLU IHKARS SAKotek A.RÜÇHAN USLUSAMED RAHATLISEMRA PAYDAŞSEMİHA URVAYSelek U.Sezer A.TEKUZMAN GTURGUT MYAVUZ ATAKAN SEZERYuksel O.

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.